Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>Products>This Product

C18 (17%) 3mL/500mg

Product Description
Solid Phase Extraction Columns

Fast clean extracts
High recoveries
Largest range of SPE columns
Custom columns service
SPE Accessories

The Q-SPE range of Solid Phase Extraction Columns are available in all the chemistries in use today, as columns, discs, cartridges and 96-well plates. The bonded particles have hydrophilic characteristic, resulting in broader analyte selectivity via retention of both hydrophobic and hydrophilic moieties. The high purity 60A, 50 micron silica has the least Silanol activity compared to many other silicas, producing rapid, accurate, sensitive and reproducible results. Q-SPE Columns are available in sizes from 1mL to 60mL with sorbent weights from 50mg to 10gms. Our custom column service is available for customers requiring specific sizes of columns or weights of sorbents. We also work with clients on specific projects requiring special packings and column treatments; please contact us to discuss your requirements.

To view the full range of Greyhound Chromatography products, visit
Product C18 (17%) 3mL/500mg
Company Greyhound Chromatography - Products
Price Request a quote
More Information View company product page
Catalog Number 31-100043
Quantity Unspecified
Company Logo

Greyhound Chromatography - Products
Greyhound Chromatography and Allied Chemicals, 6 Kelvin Park, Birkenhead, Merseyside, United Kingdom CH41 1LT

Tel: +44 151 649 4000
Fax: +44 151 649 4001

Scientific News
Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health.
Chemical Design Made Easier
Rice University scientists prepare elusive organocatalysts for drug and fine chemical synthesis.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Giant Molecules Inhibit Ebola Infection
European researchers have designed a "giant" molecule formed by thirteen fullerenes covered by carbohydrates which, by blocking this receptor, are able to inhibit the cell infection by an artificial ebola virus model.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Fighting Pain with Ketamine
Researchers at the Texas A&M Health Science Center are using ketamine, a drug that already exists as an anesthetic, to treat pain.
Possible New Treatment for Neurodegenerative Diseases Found
Researchers at the University of Liverpool have found that a well-established anti-epileptic drug could also be used as a treatment for neurodegenerative diseases.
Breast Cancer Drug Beats Superbug
Tamoxifen helps white blood cells clear multidrug-resistant bacteria in lab and mouse studies.

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos